The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Nitric oxide mediated venodilator effects of nebivolol.
Open accessAbstract
1. Nebivolol, a selective beta 1‐adrenoceptor antagonist with antihypertensive effects, has haemodynamic effects suggestive of a direct vasodilator action. 2. The dorsal hand vein technique was used to determine whether nebivolol has venodilator action in vivo in man. 3. Nebivolol and atenolol were infused into the phenylephrine preconstricted superficial hand veins of 11 healthy male volunteers. In separate studies L‐NMMA (0.1 microgram min‐1) was pre‐ and co‐infused with nebivolol to determine whether nitric oxide (NO) mediated mechanisms were present. Further studies with prostaglandin F2 alpha (PGF2 alpha) preconstriction were performed to exclude an alpha‐ adrenergic antagonistic effect of nebivolol. Effects of L‐NMMA infusion on nitroglycerin venodilation were also determined. 4. Nebivolol produced a dose dependent venodilation, (72 +/‐ 18% maximum), whereas atenolol produced no significant venodilation. At doses of nebivolol producing plasma concentrations comparable with plasma levels achieved after standard oral dosing (10(‐13)‐10(‐12) mol min‐1) small (14 +/‐ 6% and 23 +/‐ 8%) but significant (P < 0.05) venodilation was observed. 5. The venodilator response to nebivolol was significantly reduced by infusion of L‐NMMA (maximum dilation 18% vs 72%, P < 0.01). Venodilator responses to nitroglycerin were unaffected by L‐NMMA infusion. A venodilator effect to nebivolol was also seen following preconstriction with PgF2 alpha (40 +/‐ 20% maximum). 6. Nebivolol has nitric oxide mediated, venodilator effects in man.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
Palmer, R. M. J., Ferrige, A. G., & Moncada, S. (1987) · Nature · doi:10.1038/327524a0 · Cited by 10,704
Cited by
Nitric Oxide as a Signaling Molecule in the Vascular System: An Overview
Ignarro, L. J., Cirino, G., Casini, A., & Napoli, C. (1999) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199912000-00016 · Cited by 763
Ignarro, L. J., Napoli, C., & Loscalzo, J. (2002) · Circulation Research · doi:10.1161/hh0102.102330 · Cited by 491
Vasoprotection by nitric oxide: mechanisms and therapeutic potential
Gewaltig, M. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00327-9 · Cited by 370
Cancer Therapy–Induced Cardiotoxicity: Basic Mechanisms and Potential Cardioprotective Therapies
Hahn, V. S., Lenihan, D. J., & Ky, B. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.113.000665 · Cited by 264
Nebivolol vs Amlodipine as First-line Treatment of Essential Arterial Hypertension in the Elderly
Mazza, A., Gil-Extremera, B., Maldonato, A., Toutouzas, T., & Pessina, A. C. (2002) · Blood Pressure · doi:10.1080/080370502760050421 · Cited by 57
Metadata
- Authors
- Bowman, A., Chen, C., & Ford, G.
- Venue
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 1994-09
- Volume
- 38
- Issue
- 3
- Pages
- 199-204
- ISSN
- 0306-5251 (ISSN-L)
- 1365-2125
- OpenAlex
- W2058950521
- Cited by
- 190
- References
- 1
- FWCI
- 0.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nitric oxide mediated venodilator effects of nebivolol. https://app.cochat.ai/papers/10.1111/j.1365-2125.1994.tb04342.x
- The paper
- Bowman, A., Chen, C., & Ford, G. (1994). Nitric oxide mediated venodilator effects of nebivolol. British Journal of Clinical Pharmacology. https://doi.org/10.1111/j.1365-2125.1994.tb04342.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.